On October 18, 2026, India Today published a report on perimenopause symptoms beyond hot flushes featuring Dr Shivika Gupta, a fertility specialist at Birla Fertility & IVF in Gurugram.
A hot-flush-centred picture leaves too much out
A picture of perimenopause built only around hot flushes and irregular periods leaves out much of the experience described in the report. India Today places sleep, concentration and joint comfort alongside those familiar signs.
The update here concerns public understanding rather than a replacement for established medical care. The report challenges a narrow symptom picture without proposing that every physical or emotional change in midlife should be attributed to hormones.
The report connects symptoms without reducing them to hormones
This coverage is a news explainer rather than a new clinical study or treatment guideline. It supplies neither prevalence figures nor a ranking of the most common symptoms. Its useful contribution is a broader account of possible symptoms and the clinical questions they raise.
Symptoms can extend beyond temperature and periods
- The transition does not follow one fixed timetable. India Today describes perimenopause as the transition before menopause, involving fluctuating ovarian hormone levels that gradually change. It says this phase can last several months or years and that symptoms may appear before periods become irregular. That timing makes the overall pattern relevant to a clinical conversation. Regular periods alongside anxiety or fatigue are not enough on their own to establish perimenopause.
- Brain fog belongs beside sleep in the discussion. The report describes difficulty concentrating, memory lapses and trouble finding words. Its explanation allows for a hormonal contribution to cognition while noting that poor sleep can also affect attention and memory. This makes sleep part of the account rather than a separate concern to set aside. A conversation about emotional and cognitive changes together can give these experiences more useful context than a symptom label alone.
- Anxiety may have overlapping contributors. India Today includes anxiety and mood changes among experiences that may occur during the transition. It also says anxiety is not always hormonal: stress and mental-health conditions can overlap with hormonal change. Psychological support may therefore remain relevant within care. The practical implication is not to choose between a hormonal explanation and a psychological one before the individual situation has been assessed.
- Joint discomfort deserves attention in its own right. The report highlights pain or stiffness that can affect everyday movement, including discomfort in the hands and knees or hips. This brings physical comfort into a discussion that might otherwise stay focused on hot flushes. It also gives a more concrete description than simply feeling different in midlife. Where movement is affected, the effect on daily life belongs in the clinical account alongside the location and pattern of discomfort.
- Skin, hair and body changes need a wider frame. India Today includes skin or hair changes and discusses shifts in abdominal fat distribution. Its account also identifies ageing and activity as possible contributors, alongside sleep and metabolic factors. That framing resists the idea that a change in appearance or body composition has one automatic explanation. These concerns can be discussed without turning them into evidence that hormones are necessarily the cause or that weight loss is the required answer.
- Intimate and urinary symptoms are part of the picture. The report also discusses vaginal dryness or discomfort and urinary symptoms, alongside changes in libido. These sit within its broader account rather than outside the definition of midlife health. Their inclusion matters because the conversation is not limited to symptoms visible to other people. Comfort and sexual wellbeing belong in an assessment of how the transition may be affecting daily life and quality of life.
Clinical assessment brings the pattern into focus
- The history matters more than counting symptoms. According to India Today, clinicians may consider age and menstrual history alongside the symptoms themselves. Medication use and medical background can also shape the assessment. A collection of symptoms is therefore a starting point for discussion rather than a score that confirms a diagnosis. The useful account connects what has changed with its timing and effect on ordinary activities, rather than simply matching experiences to a longer online list.
- Other conditions may explain overlapping changes. The report names thyroid disorders and anaemia among possible explanations for symptoms that can resemble those attributed to perimenopause. Its examples include fatigue and hair changes, with mood symptoms and menstrual irregularity also needing context. Unexplained weight changes belong in that wider assessment too. This is the reason to keep possible thyroid overlap in view rather than treating the timing of a symptom as proof of its cause.
- Testing should follow the presentation. India Today says a clinician may select thyroid function tests or a complete blood count, with iron studies another possibility depending on the circumstances. It cautions that a single hormone measurement can be difficult to interpret because levels fluctuate. For wider clinical context, the Irish Pharmacy Union says otherwise healthy people aged 45 or older with typical symptoms can be assessed clinically without routine ovarian hormone testing. Its professional guidance notes that FSH can fluctuate; this is not a blanket rule against testing in every situation.
- Persistence and severity change the conversation. India Today advises assessment when symptoms persist or become severe, progressively worsen or interfere with daily life. It specifically flags persistent joint pain and new or severe headaches, alongside unexplained weight changes. Those features should remain visible in the discussion rather than being absorbed into a broad perimenopause label. The report's message is that recognition of the transition should not become a reason to dismiss a concern that needs individual attention.
- Certain bleeding patterns require medical assessment. The article identifies heavy bleeding and bleeding between periods as reasons for clinical attention. It also flags bleeding after sex and any bleeding after menopause. These are not presented as changes to quietly accept because periods can alter during perimenopause. Keeping this distinction clear prevents a general description of menstrual change from becoming reassurance about a bleeding pattern that should be assessed by a qualified clinician.
Support should fit the individual rather than the checklist
- Lifestyle measures are foundations rather than guaranteed solutions. India Today suggests regular aerobic and resistance exercise alongside attention to sleep. Its nutrition discussion includes adequate protein and fibre, with calcium-rich foods also named. The report states that these measures may not be sufficient for everyone, so their inclusion should not become a test of personal effort. A flexible approach to midlife nutrition fits this discussion better than presenting a restrictive food plan as the answer to a broad symptom pattern.
- Treatment decisions need a separate clinical discussion. The report does not put forward one management approach for every woman. It says decisions about menopausal hormone therapy depend on individual risks and benefits, together with medical history. A longer list of recognised symptoms does not automatically translate into a longer list of treatment indications. The role of the coverage is to make concerns easier to describe; choosing care remains a personal decision to make with a qualified clinician.
Broader recognition should lead to better clinical conversations
The useful direction for clinical practice is wider recognition of symptoms paired with assessment that preserves room for other explanations and care shaped around the individual.
How Refemina helps
A longer perimenopause symptom list can become another sales route for hormones and supplements; Refemina approaches midlife change as a subject for clear explanation rather than a product answer. Its research-led coverage helps women sort conflicting messages about hormonal change while keeping physical comfort, sexual wellbeing and confidence within the conversation.
Explore Resources
Sources
- Perimenopause symptoms beyond hot flushes: 10 signs women should not ignore
- Menopause in practice: A pharmacist's guide - IPU
